Logo image of MDAI

SPECTRAL AI INC (MDAI) Stock Fundamental Analysis

NASDAQ:MDAI - Nasdaq - US84757T1051 - Common Stock - Currency: USD

1.95  -0.04 (-2.01%)

After market: 1.926 -0.02 (-1.23%)

Fundamental Rating

1

Overall MDAI gets a fundamental rating of 1 out of 10. We evaluated MDAI against 190 industry peers in the Health Care Equipment & Supplies industry. MDAI has a bad profitability rating. Also its financial health evaluation is rather negative. MDAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MDAI has reported negative net income.
In the past year MDAI has reported a negative cash flow from operations.
MDAI Yearly Net Income VS EBIT VS OCF VS FCFMDAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

MDAI has a worse Return On Assets (-95.84%) than 82.45% of its industry peers.
Industry RankSector Rank
ROA -95.84%
ROE N/A
ROIC N/A
ROA(3y)0.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDAI Yearly ROA, ROE, ROICMDAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 1K

1.3 Margins

MDAI has a Gross Margin of 45.34%. This is in the lower half of the industry: MDAI underperforms 62.77% of its industry peers.
MDAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDAI Yearly Profit, Operating, Gross MarginsMDAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

MDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDAI has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MDAI has a worse debt to assets ratio.
MDAI Yearly Shares OutstandingMDAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M
MDAI Yearly Total Debt VS Total AssetsMDAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -3.72, we must say that MDAI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.72, MDAI is doing worse than 66.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.72
ROIC/WACCN/A
WACC9.07%
MDAI Yearly LT Debt VS Equity VS FCFMDAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

MDAI has a Current Ratio of 0.73. This is a bad value and indicates that MDAI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.73, MDAI is doing worse than 93.09% of the companies in the same industry.
MDAI has a Quick Ratio of 0.73. This is a bad value and indicates that MDAI is not financially healthy enough and could expect problems in meeting its short term obligations.
MDAI's Quick ratio of 0.69 is on the low side compared to the rest of the industry. MDAI is outperformed by 90.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.69
MDAI Yearly Current Assets VS Current LiabilitesMDAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.82% over the past year.
MDAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 692.56%.
EPS 1Y (TTM)4.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.12%
Revenue 1Y (TTM)692.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%137.59%

3.2 Future

MDAI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.86% yearly.
MDAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.34% yearly.
EPS Next Y63.86%
EPS Next 2Y26.87%
EPS Next 3Y19.75%
EPS Next 5Y16.86%
Revenue Next Year58.22%
Revenue Next 2Y17.49%
Revenue Next 3Y26.82%
Revenue Next 5Y34.34%

3.3 Evolution

MDAI Yearly Revenue VS EstimatesMDAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
MDAI Yearly EPS VS EstimatesMDAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDAI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDAI Price Earnings VS Forward Price EarningsMDAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDAI Per share dataMDAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

MDAI's earnings are expected to grow with 19.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.87%
EPS Next 3Y19.75%

More info and screens

0

5. Dividend

5.1 Amount

MDAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPECTRAL AI INC

NASDAQ:MDAI (2/21/2025, 8:00:01 PM)

After market: 1.926 -0.02 (-1.23%)

1.95

-0.04 (-2.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-25 2025-03-25/amc
Inst Owners11.68%
Inst Owner Change-84.46%
Ins Owners34.73%
Ins Owner Change0%
Market Cap41.44M
Analysts84
Price Target5.22 (167.69%)
Short Float %8.11%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.08%
Min EPS beat(2)-2.3%
Max EPS beat(2)52.47%
EPS beat(4)3
Avg EPS beat(4)20.12%
Min EPS beat(4)-2.3%
Max EPS beat(4)52.47%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.02%
Min Revenue beat(2)12.08%
Max Revenue beat(2)13.96%
Revenue beat(4)2
Avg Revenue beat(4)3.11%
Min Revenue beat(4)-11.4%
Max Revenue beat(4)13.96%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.64%
EPS NY rev (1m)6.43%
EPS NY rev (3m)12.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS1.28
BVpS-0.2
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -95.84%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.34%
FCFM N/A
ROA(3y)0.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.69
Altman-Z -3.72
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.12%
EPS Next Y63.86%
EPS Next 2Y26.87%
EPS Next 3Y19.75%
EPS Next 5Y16.86%
Revenue 1Y (TTM)692.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%137.59%
Revenue Next Year58.22%
Revenue Next 2Y17.49%
Revenue Next 3Y26.82%
Revenue Next 5Y34.34%
EBIT growth 1Y-29.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.38%
EBIT Next 3Y17.82%
EBIT Next 5Y19.67%
FCF growth 1Y-1620.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1620.43%
OCF growth 3YN/A
OCF growth 5YN/A